Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Large B-Cell, Diffuse 19Lymphoma 15Burkitt Lymphoma 15Neuroblastoma 12Lymphoma, Non-Hodgkin 11Recurrence 10Lymphoma, Follicular 9Leukemia 9Lymphoma, T-Cell, Peripheral 6Lymphoma, T-Cell 6Lymphoma, B-Cell 6Leukemia, Biphenotypic, Acute 6Brain Neoplasms 6Lymphoma, Mantle-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Central Nervous System Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4HIV Infections 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Sarcoma, Ewing 3Sarcoma 3Medulloblastoma 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3

Interventions

siplizumab 1liposomal doxorubicin 1Vincristine 1Rituximab 1Prednisone 1Everolimus 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Subcutaneous panniculitis-like T-cell lymphoma × Vincristine × Clear all
NCT01445535 2021-11-03

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 18 charts
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡